Evolus Stock

Evolus P/B

The P/B (Price-to-Book Ratio) of Evolus (EOLS) as of Aug 10, 2026 is -12.06. In the previous year, P/B (Price-to-Book Ratio) was 50.48 — a change of -123.90% (lower).

P/B

-12.06

YoY

-123.90%

Last updated:

P/B (Price-to-Book Ratio) of Evolus is 2026 -12.06 . P/B (Price-to-Book Ratio) of Evolus was 2025 50.48 . It decreases by -123.90% lower compared to the previous year.
Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

P/B (Price-to-Book Ratio) of Evolus is -12.06 in 2026.

P/B (Price-to-Book Ratio) of Evolus changed from 50.48 to -12.06, representing a -123.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Evolus since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Evolus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Evolus

All Key Metrics — Evolus